➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Harvard Business School
McKesson
Boehringer Ingelheim
Mallinckrodt

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Patent: 8,268,352

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,268,352
Title:Modified release composition for highly soluble drugs
Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
Inventor(s): Vaya; Navin (Gujarat, IN), Karan; Rajesh Singh (Gujarat, IN), Nadkarni; Sunil Sadanand (Gujarat, IN), Gupta; Vinod Kumar (Gujarat, IN)
Assignee: Torrent Pharmaceuticals Limited (Ahmedabad, IN)
Application Number:11/134,632
Patent Claims:see list of patent claims

Details for Patent 8,268,352

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 003 2001-11-14   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Jubilant Hollisterstier Llc POSITIVE SKIN TEST CONTROL - HISTAMINE histamine INJECTION 103891 1 1995-06-15   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 search
Alk-abello, Inc. HISTAMINE POSITIVE histamine phosphate INJECTION, SOLUTION 103754 1 1989-10-23   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 search
Smith And Nephew REGRANEX becaplermin GEL; TOPICAL 103691 001 1997-12-16   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Sigma Tau ONCASPAR pegaspargase VIAL 103411 001 1994-02-01   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,268,352

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2004012699   Start Trial
United States of America 2004096501   Start Trial
United States of America 2006018933   Start Trial
United States of America 2006018934   Start Trial
United States of America 7976871   Start Trial
United States of America 8216609   Start Trial
Australia 2003274680   Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Merck
McKinsey
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.